REFERENCES
- Albert FW, Schmidt U. Sulphinpyrazone or acetyl-salicylic acid to prevent postoperative thrombus form-tion in arteriovenous fistulas of haemodialysis patients. Haemostasis 1979: 42,63, Abstract 0140.
- Andrassy K, Malluche H, Bornefeld H, et al. Prevention of p.o. clotting of AV Cimino fistulae with acetyl-salicylic acid: results of a prospective double blind study. Klin Wschr 1974; 52: 348–349.
- Antiplatelet Trialists' Collaboration. Secondary preven-tion of vascular disease by prolonged antiplatelet treatment. Br Med J 1988; 296: 320–331.
- Antiplatelet Trialists' Collaboration. Collaborative over-view of randomised trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatet therapy. Br Med J 1994; 308: 159–168.
- Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. New Eng J Med 1966; 275: 1089–1093.
- Dodd NJ, Tumey JH, Weston MJ. Ticlopidine preserves vascular access for haemodialysis. 6th Congress of the Ligue Mediterrane'enne contre les Maladies Thrombo-emboliques, Monte Carlo, 23–25 October, 1980: Ab-stract 326F.
- Ell S, Mihindukulasuriya JCL, O'Brien JR, Polak A, Vernham G. Ticlopidine in the prevention of blockage of fistulae and shunts. Haemostasis 1982; 12: 180, Abstract 332.
- Fiskerstrand CE, Thompson IW, Burnet ME, Williams P. Anderton JL. Double blind randomised trial of the effect of ticlopidine in arteriovenous fistulas for hemodialysis. Artif Organs 1985; 9: 61–63.
- Galato R, Bertoli S, Mandolfo S. Prevenzione dell'oc-clusione trombotica dell'accesso vascolare alla emodia-lisi con ticlopidina. In: Anonyme. Recenti acquisizione in tema di terapia antipiastrinice: Simposio satellite all'83 Congresso Della Societa Italiana Di Medicina Interna, Roma 20 Ottobre 1982. Milan, Masson, 1982: 185–189.
- Gent M, Blakely JA, Easton JD, et al. The Canadian-American ticlopidine study (CATS) in thromboembolic stroke. Lancet 1989; i: 1215–1220.
- Grontoft K-CH, Mulec H, Guiterez A, Olander R. Thromboprophylactic effect of ticlopidine in arterio-venous fistulas for haemodialysis. Scand J Urol Nephrol 1985; 19: 55–57.
- Hass WK, Easton JD, Adams HP, et al. for the Ticlopidine Aspirin Stroke Study Group. A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New Engl J Med 1989; 321: 501–507.
- Harter HR, Burch JW, Majerus PW, et al. Prevention of thrombosis in patients on haemodialysis by low-dose aspirin. New Eng J Med 1979; 301: 577–579.
- Janzon L, Bergqvist D, Boberg J, et al. Prevention of myocardial infarction and stroke in patients with intermittent claudication: Effects of ticlopidine. Results from Stims, the Swedish ticlopidine multicentre study, J Internal Med 1990; 227: 301–308.
- Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsch J, Gent M. Arteriovenous-shunt thrombosis: prevention by sulphinpyrazone. New Eng J Med 1974; 290: 304–306.
- Kinnaert P. Vereerstraeten P. Toussaint C, Van Geertruyden J. Nine year's experience with internal arteriovenous fistulas for haemodialysis. A study of some factors influencing the results. Br J Surg 1974; 64: 242–246.
- Kobayashi K, Maeda K, Koshikawa S, Kawaguchi Y, Shimizu N, Naito C. Antithrombotic therapy with ticlopidine in chronic renal failure patients on main-tenance hemodialysis. A multicenter collaborative double blind study. Thrombosis Res 1980; 20: 255–261.
- McArdle CS, Hole D. Impact of variability among surgeons on post-operative morbidity and mortality and ultimate survival. Br Med J 1991; 302: 1501–1505.
- McTavish D, Faulds D, Goa KL. Ticlopidine: An updated review of its phamacology and therapeutic use in platelet-dependent disorders. Drugs 1990; 40: 238–259.
- Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 103–115.
- Rohr MS, Browder W, Frentz GD, McDonald JC. Arteriovenous fistulas for long-term dialysis. Arch Surg 1978; 113:153–155.
- Saltiel E, Ward A. Ticlopidine: a review of its pharmacodynamic and pharmakokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 1987; 34: 222–262.
- SAS Institute, Inc. User's Guide: Statistics., Version 5. Cary NC (ED). SAS Institute Inc. 1985.
- Thompson BW, Barbour G, Bissett J. Internal arterio-venous fistula for hemodialysis. Am J Surg 1972; 124: 785–788.
- Thomsen MB, Deurell D-I, Elfstro-m J, Alm A. What causes the failure of arteriovenous fistulas? Acta Chir Scand 1983; 149: 371–376.